STOCKHOLDERS' EQUITY (Tables)

3 Months Ended

Mar. 31, 2026

STOCKHOLDERS' EQUITY

Schedule of stock option activity


						Weighted
				Weighted		average
				average		remaining		Aggregate
				exercise		contractual		Intrinsic
		Number of		price		life		value
		options**		$		Years		$
Options outstanding at beginning of period		336,768		46.21		8.16		4
Options granted		8,500		11.32		—		—
Options exercised		—		—		—		—
Options expired		(46,885)		62.73		—		—
Options forfeited		(7,067)		13.03		—		—

Options outstanding at end of period		291,316		43.34		8.25		2

Options vested and expected to vest at end of period		103,970		33.66		8.16		—

Exercisable at end of period		137,020		66.34		7.75		2

(**) See note 1e regarding reverse share split.

Schedule of restricted stock option activity


								Number of
								Restricted shares**

Restricted shares outstanding at beginning of year								613,465
Restricted shares granted								2,127
Restricted shares forfeited								(3,031)

Restricted shares outstanding at end of period								612,561

(**) See note 1e regarding reverse share split.

Schedule of assumptions used to estimate the fair values of the options granted to employees, directors and non-employees


		Three months ended
		March 31,
		2026		2025
Volatility		98.97-101.10	%	—	%
Risk-free interest rate		3.79-3.83	%	—	%
Dividend yield		—	%	—	%
Expected life (years)		5.88		—

Schedule of compensation cost


		Three months ended
		March 31,
		2026			2025
Cost of revenues		$	5		$	10
Research and development			92			526
Sales and marketing			133			815
General and administrative			1,211			991

Total stock-based compensation expenses		$	1,441		$	2,342